Publication at First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové |
2014
Abstract
This supplement contains revision of guidelines for treatment of multiple myeloma with lenalidomide and new guidelines for treatment of multiple myeloma with pomalidomide and carfilzomib.